A detailed history of Baillie Gifford & CO transactions in Codexis, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 1,813,800 shares of CDXS stock, worth $7.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,813,800
Previous 2,708,802 33.04%
Holding current value
$7.13 Million
Previous $8.4 Million 33.48%
% of portfolio
0.0%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$2.62 - $3.71 $2.34 Million - $3.32 Million
-895,002 Reduced 33.04%
1,813,800 $5.59 Million
Q2 2024

Jul 25, 2024

SELL
$2.65 - $3.92 $1.95 Million - $2.89 Million
-736,507 Reduced 21.38%
2,708,802 $8.4 Million
Q1 2024

May 01, 2024

BUY
$2.59 - $4.65 $67,899 - $121,904
26,216 Added 0.77%
3,445,309 $12 Million
Q4 2023

Jan 26, 2024

SELL
$1.54 - $3.37 $970,929 - $2.12 Million
-630,474 Reduced 15.57%
3,419,093 $10.4 Million
Q3 2023

Nov 13, 2023

SELL
$1.5 - $3.75 $3.14 Million - $7.84 Million
-2,090,931 Reduced 34.05%
4,049,567 $7.65 Million
Q2 2023

Jul 28, 2023

BUY
$2.21 - $4.43 $73,104 - $146,539
33,079 Added 0.54%
6,140,498 $17.2 Million
Q1 2023

May 03, 2023

SELL
$3.81 - $6.76 $392,932 - $697,172
-103,132 Reduced 1.66%
6,107,419 $25.3 Million
Q4 2022

Jan 24, 2023

SELL
$4.26 - $6.84 $3.65 Million - $5.87 Million
-857,568 Reduced 12.13%
6,210,551 $28.9 Million
Q3 2022

Oct 27, 2022

SELL
$6.06 - $12.86 $2.01 Million - $4.27 Million
-331,948 Reduced 4.49%
7,068,119 $42.8 Million
Q2 2022

Aug 08, 2022

BUY
$8.35 - $21.89 $112,215 - $294,179
13,439 Added 0.18%
7,400,067 $77.4 Million
Q1 2022

May 05, 2022

BUY
$16.97 - $31.93 $3.47 Million - $6.52 Million
204,226 Added 2.84%
7,386,628 $152 Million
Q4 2021

Jan 20, 2022

BUY
$25.61 - $41.78 $14.4 Million - $23.5 Million
563,579 Added 8.51%
7,182,402 $225 Million
Q3 2021

Oct 19, 2021

SELL
$19.65 - $27.99 $722,176 - $1.03 Million
-36,752 Reduced 0.55%
6,618,823 $154 Million
Q2 2021

Aug 02, 2021

BUY
$17.48 - $25.46 $12.7 Million - $18.5 Million
725,024 Added 12.23%
6,655,575 $151 Million
Q1 2021

May 06, 2021

BUY
$18.08 - $28.8 $2.44 Million - $3.89 Million
135,153 Added 2.33%
5,930,551 $136 Million
Q4 2020

Feb 10, 2021

BUY
$11.7 - $23.41 $5.08 Million - $10.2 Million
434,137 Added 8.1%
5,795,398 $127 Million
Q3 2020

Nov 12, 2020

SELL
$11.21 - $13.82 $77,528 - $95,579
-6,916 Reduced 0.13%
5,361,261 $62.9 Million
Q2 2020

Aug 12, 2020

BUY
$9.8 - $12.77 $12.6 Million - $16.4 Million
1,280,860 Added 31.34%
5,368,177 $61.2 Million
Q1 2020

May 08, 2020

BUY
$8.78 - $18.6 $2.63 Million - $5.57 Million
299,283 Added 7.9%
4,087,317 $45.6 Million
Q4 2019

Feb 10, 2020

BUY
$13.12 - $17.06 $6.78 Million - $8.82 Million
516,934 Added 15.8%
3,788,034 $60.6 Million
Q3 2019

Nov 07, 2019

BUY
$12.75 - $19.01 $870,519 - $1.3 Million
68,276 Added 2.13%
3,271,100 $44.9 Million
Q2 2019

Aug 08, 2019

BUY
$17.0 - $21.88 $2.47 Million - $3.18 Million
145,269 Added 4.75%
3,202,824 $59 Million
Q1 2019

May 01, 2019

BUY
$15.53 - $22.15 $2.69 Million - $3.83 Million
173,065 Added 6.0%
3,057,555 $0
Q4 2018

Feb 14, 2019

BUY
$14.06 - $22.57 $1.17 Million - $1.88 Million
83,253 Added 2.97%
2,884,490 $48.2 Million
Q3 2018

Nov 13, 2018

BUY
$13.35 - $19.1 $2.07 Million - $2.96 Million
154,997 Added 5.86%
2,801,237 $48 Million
Q2 2018

Jul 17, 2018

BUY
$10.35 - $16.45 $3.55 Million - $5.65 Million
343,261 Added 14.91%
2,646,240 $38.1 Million
Q1 2018

May 10, 2018

BUY
$8.0 - $12.8 $3.68 Million - $5.9 Million
460,578 Added 25.0%
2,302,979 $25.3 Million
Q4 2017

Feb 13, 2018

BUY
$5.85 - $8.4 $2.13 Million - $3.06 Million
364,304 Added 24.65%
1,842,401 $15.4 Million
Q3 2017

Oct 20, 2017

BUY
$4.9 - $6.65 $81,751 - $110,948
16,684 Added 1.14%
1,478,097 $9.83 Million
Q2 2017

Aug 10, 2017

BUY
N/A
1,461,413
1,461,413 $7.97 Million

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $257M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.